Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
ENTX
$2.46
-2.77%
ENTX
· Entera Bio Ltd.
$2.46
-0.07 (-2.77%)
At close · Oct 7
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 7, 2026
The latest filing states the doubt was alleviated.
“Following the closing of the private placement and receipt of the related net proceeds, management concluded that substantial doubt about the Company’s ability to continue as a going concern no longer exists.”View the 10-Q filed Aug 7, 2026
Market Cap
$453.63M
Shares
173.14M
Volume · Oct 7
679.48K
Avg daily vol (3M)
1.79M
All webcasts
Earnings call · FY2022 Q1
Entera Bio Ltd. (ENTX) Q1 2022 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$68,000
-56.7% YoY
Diluted EPS
$0.13
Gross margin
20.6%
-32.9 pp YoY
Net income
-$3.78M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed May 12, 2022 · complete as-filed document
SEC periodic report
10-Q report
Filed May 12, 2022 · complete as-filed document